המוקומפלטן פי 1 ג'
csl behring ltd., israel - human fibrinogen - אבקה להמסה להזרקה\אינפוזיה - human fibrinogen 900 - 1300 mg / 1 vials - fibrinogen, human - fibrinogen, human - haemocomplettan p 1g/2g, fibrinogen concentrate (human) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.haemocomplettan p 1g/2g is not indicated for dysfibrinogenemia.
המוקומפלטן פי 2 ג'
csl behring ltd., israel - human fibrinogen - אבקה להמסה להזרקה\אינפוזיה - human fibrinogen 1800 - 2600 mg / 1 vials - fibrinogen, human - fibrinogen, human - haemocomplettan p 1g/2g, fibrinogen concentrate (human) is indicated for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia.haemocomplettan p 1g/2g is not indicated for dysfibrinogenemia.
הפטקט cp
kamada ltd, israel - human hepatitis b immunoglobulin - תמיסה לאינפוזיה - human hepatitis b immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - prophylaxis against hepatitis b in adults and children over 2 years of age who have not been vaccinated against hepatitis b (including persons whose vaccination is incomplete or missing) who are at risk of infection with hepatitis b by accidental contact with hepatitis b virus containing material following: - percutaneous exposure (e.g. accidental needle stick). - direct mucous membrane contact. when the administration of an intramuscular hepatitis b immunoglobulin is not possible. the immunoglobulin should be administered in association with hepatitis b vaccine. prophylaxis against re-infection of a transplanted liver in patients who carry the surface antigen of the hepatitis b virus. immunoprophylaxis of hepatitis b in the newborn of a hepatitis b virus carrier mother.
אינטראטקט 50 גרםליטר
kamada ltd, israel - human normal immunoglobulin - תמיסה לאינפוזיה - human normal immunoglobulin 50 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - 1.replacement therapy in: primary immunodeficiency syndromes such as: - congenital agammaglobulinemia and hypogammaglobulinemia - common variable immunodeficiency - severe combined immunodeficiency - wiskott aldrich syndromemyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinemia and recurrent infectionschildren with congenital aids and recurrent infections2. immunomodulation: - idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count- guillain barr? syndrome- kawasaki disease3. allogeneic bone marrow transplantation
בזפיברט 400
medison pharma ltd - bezafibrate - טבליות עם שחרור מושהה - bezafibrate 400 mg - bezafibrate - bezafibrate - hyperlipidemia of types iia, iib, iii, iv, v in patients where diet alone is insufficient.
פנידין 18 מג
trima israel pharmaceutical products maabarot ltd - methylphenidate hydrochloride - טבליות בשחרור ממושך - methylphenidate hydrochloride 18 mg - methylphenidate
פנידין 18 מג
trima israel pharmaceutical products maabarot ltd - methylphenidate hydrochloride - טבליות בשחרור ממושך - methylphenidate hydrochloride 18 mg - methylphenidate
פנידין 27 מג
trima israel pharmaceutical products maabarot ltd - methylphenidate hydrochloride - טבליות בשחרור ממושך - methylphenidate hydrochloride 27 mg - methylphenidate
פנידין 27 מג
trima israel pharmaceutical products maabarot ltd - methylphenidate hydrochloride - טבליות בשחרור ממושך - methylphenidate hydrochloride 27 mg - methylphenidate
פנידין 36 מג
trima israel pharmaceutical products maabarot ltd - methylphenidate hydrochloride - טבליות בשחרור ממושך - methylphenidate hydrochloride 36 mg - methylphenidate